Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users

ISSN: 00195847
11Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Detection of hepatitis B surface antigen (HBsAg), anti hepatitis C virus (HCV) antibody and anti human immunodeficiency virus (HIV) antibody was carried out in serum samples from 250 injecting drug users (IDUs) from a deaddiction centre, Shalom, in Churachanpur district, Manipur during the period of August-October, 2002. One hundred and forty-nine (59.6%) IDUs were positive for HIV antibody, 226 (90.4%) were positive for anti HCV antibody and 27 (10.8%) were positive for HBsAg. There was coinfection of HIV, hepatitis B virus (HBV) and HCV in 15 (6%) of the IDUs. The coinfection of HBV and HCV was found in 12 cases (4.8%) and coinfection of HIV and HCV was found in 131 cases (52.4%). HIV and HCV were the highest among the coinfection of IDUs. The IDUs were in sexually active age group with a risk of infection to their sexual partner.

Cite

CITATION STYLE

APA

Devi, K. S., Singh, N. B., Singh, H. L., & Singh, Y. M. (2009). Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users. Journal of the Indian Medical Association, 107(3), 144–147.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free